8 US Stocks Gain Led by Hershey, Starbucks, and Humana Guidance Raise

Key Takeaways

  • Eight US stocks including Hershey, Starbucks, and Humana posted gains in the recent trading session.
  • Humana raised its full-year adjusted EPS guidance to at least $9.50 from at least $9.00, citing better-than-expected medical cost controls.
  • Hershey revised its 2026 organic sales growth forecast to 3% from a range of 3% to 3.5%.

Eight US stocks including Hershey (HSY.US), Starbucks (SBUX.US), Sysco (SYY.US), J.M. Smucker (SJM.US), Humana (HUM.US), Texas Pacific Land (TPL.US), Tyler Technologies (TYL.US), and Equifax (EFX.US) posted gains in recent trading. Hershey rose 2.51% to $177.16 amid cocoa and sugar cost pressures, while Starbucks climbed 2.11% to $108.69 following stronger-than-expected same-store sales growth. Humana advanced 1.85% to $458.34 after raising its full-year adjusted earnings per share guidance to at least $9.50 from at least $9.00, citing better-than-expected medical cost controls. The trading session reflected a mix of operational updates and sector-specific dynamics across consumer goods, healthcare, and technology services.

Hershey Faces Cocoa Cost Pressures and Consumer Shift to Smaller Packages

Hershey (HSY.US) closed at $177.16, up 2.51%, with trading volume of 152,500 shares. The opening price was $177.31, with an intraday high of $178.02 and low of $174.68. Average trading price stood at $176.63.

The company faces dual pressures from cocoa and sugar costs alongside consumer behavior shifts toward smaller packages and alternative confections. Hershey revised its 2026 organic sales growth forecast to 3% from a prior range of 3% to 3.5%, indicating nearly flat fourth-quarter growth. Market research data showed overall Halloween candy sales declined 6.7% year-over-year, with chocolate sales down 7.2% and milk chocolate showing particularly sharp declines. Sales of candy packages under 9 ounces rose 24% year-over-year, reflecting consumer focus on lower entry price points amid rising costs. Upstream factors include limited cocoa production in West Africa and disruptions to Brazil's sugarcane harvest, keeping raw material costs elevated. Multiple brokerages downgraded their assessments of the company following these developments.

Starbucks Reports 7.2% Global Same-Store Sales Growth

Starbucks (SBUX.US) closed at $108.69, up 2.11%, with trading volume of 269,900 shares. The opening price was $108.01, with an intraday high of $110.07 and low of $107.69. Average trading price was $109.23.

The company's latest quarterly global same-store sales growth of 7.2% exceeded market expectations. US same-store sales grew 7.7%, with average ticket size increasing approximately 5% and transaction count rising approximately 2%, demonstrating early results from CEO Brian Niccol's "Back to Starbucks" initiative. International same-store sales grew only 0.9%. Quarterly revenue of $9.1 billion came in below expectations, partly reflecting the impact of converting China stores to a licensed joint venture model.

Starbucks projected total revenue to decline approximately 1% for the new fiscal year and plans to close approximately 1%, or about 250, North American stores. The company is prioritizing AI-accelerated delivery processing, personalized digital menus with customer recognition capabilities, and simplified payment processes.

Humana Raises Full-Year EPS Guidance to At Least $9.50

Humana (HUM.US) closed at $458.34, up 1.85%, with trading volume of 57,600 shares. The opening price was $460.00, with an intraday high of $460.28 and low of $449.08. Average trading price was $456.61.

The company raised its full-year adjusted earnings per share guidance to at least $9.50 from at least $9.00, exceeding the market's prior estimate of $9.15. Third-quarter medical cost ratio in the insurance segment was 93.7%, better than analysts' estimate of 94.39%, indicating a lower proportion of premiums used for medical care than expected. Individual Medicare Advantage membership grew 23% year-over-year, aligning with the company's long-term target of approximately 25% membership growth through 2026. Third-quarter revenue of $41.16 billion exceeded market expectations of $40.46 billion, showing continued core business expansion while competitors reduce their footprint due to cost pressures.

Four Stocks Trade Without Recent Material News

Sysco (SYY.US) closed at $78.78, up 2.18%, with trading volume of 204,100 shares. The opening price was $78.02, with an intraday high of $78.78 and low of $77.67. No material financial reports, guidance updates, or major customer announcements emerged in the recent period. The company's core operations center on large-scale procurement, regional warehousing, and distribution systems serving restaurants, hotels, schools, and hospitals, with revenue primarily from food sales, cold chain distribution, private label brands, and supply chain services.

J.M. Smucker (SJM.US) closed at $135.20, up 1.89%, with trading volume of 41,900 shares. The opening price was $134.62, with an intraday high of $135.80 and low of $134.40. No company-specific news emerged within the past 14 days.

Texas Pacific Land (TPL.US) closed at $296.58, up 1.60%, with trading volume of 27,900 shares. The opening price was $287.63, with an intraday high of $300.00 and low of $286.27. No company-specific news emerged within the past 14 days.

Tyler Technologies (TYL.US) closed at $429.24, up 1.22%, with trading volume of 31,800 shares. The opening price was $428.91, with an intraday high of $431.75 and low of $427.81. Two insiders purchased approximately $694,000 worth of shares over the past year at an average price of approximately $314.10, with the most recent purchase occurring in late February. Active institutional investors held 46.6% of outstanding shares in the second quarter of 2026, an increase of 2.37% from the prior quarter. Short interest as of October 30 represented 7.8% of outstanding shares, with 3.4 days to cover.

Equifax (EFX.US) closed at $190.95, up 1.50%, with trading volume of 39,400 shares. The opening price was $190.47, with an intraday high of $191.00 and low of $189.07. No company-specific news emerged within the past 14 days.

FAQ

What drove Humana's stock gain?

Humana raised its full-year adjusted earnings per share guidance to at least $9.50 from at least $9.00, exceeding the market's prior estimate of $9.15. The company's third-quarter medical cost ratio of 93.7% came in better than analysts' estimate of 94.39%, and third-quarter revenue of $41.16 billion exceeded expectations of $40.46 billion.

Why did Hershey revise its 2026 sales growth forecast?

Hershey revised its 2026 organic sales growth forecast to 3% from a prior range of 3% to 3.5%, indicating nearly flat fourth-quarter growth. Market research data showed overall Halloween candy sales declined 6.7% year-over-year, with chocolate sales down 7.2%. The company faces elevated raw material costs from limited cocoa production in West Africa and disruptions to Brazil's sugarcane harvest.

What were Starbucks' same-store sales growth figures?

Starbucks reported global same-store sales growth of 7.2%, exceeding market expectations. US same-store sales grew 7.7%, with average ticket size increasing approximately 5% and transaction count rising approximately 2%. International same-store sales grew only 0.9%.

Disclaimer: This content is for informational purposes only and does not constitute investment advice or encourage the buying or selling of crypto assets. It is intended to provide information about industry developments and is not directly related to the services offered by Gate TR. Although information obtained from third-party sources has been carefully reviewed, Gate TR assumes no responsibility for any errors or omissions. Crypto assets involve high risks and may experience significant price fluctuations. Before making any investment decisions, you should assess your financial situation and risk tolerance, conduct your own research, and make decisions independently.